Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

AREDS-Inspired Study Challenges Omega-3 Cognitive Benefit Claims

This article was originally published in The Tan Sheet

Executive Summary

Omega-3 supplementation had no impact on cognitive function in a five-year assessment of elderly people participating in AREDS2 research, say NIH researchers. But they add in the JAMA study that longer-term use of omega-3s could result in a different outcome.

You may also be interested in...



Complaint Reminds CVS: No Support For Memory Claim In Fish Oil Study

A complaint filed by CSPI working with law firms in New York and Washington extends the dispute over cognitive claims for vitamin and supplement products from enforcement by FTC and FDA and questions from Congress to consumers' class action complaints.

Omega-3 Use Grows Despite Doubts, Herbals Rise Above NY Controversy

The Council for Responsible Nutrition’s 16th annual survey shows questions raised by researchers, state officials and media about the safety and efficacy of some supplement ingredients do not appear to slowing users’ interest in the products.

Omega-3 Use Grows Despite Doubts, Herbals Rise Above NY Controversy

The Council for Responsible Nutrition’s 16th annual survey shows questions raised by researchers, state officials and media about the safety and efficacy of some supplement ingredients do not appear to slowing users’ interest in the products.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS107860

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel